GRP and neoplasm: While ProCA1.GRP has some MRI enhancement at tumor regions after intratumoral injection, it failed to show any significant tumor enhancement in mice xenografted with PC3 cells by tail vein injection of ProCA1.GRP (Supplementary Fig. 9).